作者:Wei Tuo、Natascha Leleu-Chavain、Amélie Barczyk、Nicolas Renault、Lucas Lemaire、Philippe Chavatte、Régis Millet
DOI:10.1016/j.bmcl.2016.04.004
日期:2016.6
series of 3-carboxamido-5-aryl-isoxazoles was designed, synthesized and evaluated for their biological activity. Different pharmacomodulations have been explored and the lipophilicity of these compounds was assessed. Investigation of the in vitro biological activity led to the identification of 5 compounds as potent FAAH inhibitors, their good FAAH inhibition capacity is probably correlated with their
设计,合成和评估了其新的3-羧酰胺基-5-芳基-异恶唑系列的生物活性。已经研究了不同的药物调节,并评估了这些化合物的亲脂性。对体外生物活性的研究导致鉴定出5种化合物为有效的FAAH抑制剂,它们良好的FAAH抑制能力可能与其合适的亲脂性有关。具体而言,与迄今已知的最有效的FAAH抑制剂之一URB597相比,化合物25对FAAH表现出相似的抑制效力。